SCHEMBL20249605

SCHEMBL20249605

CCCC1(CC)C[C@]1(C(=O)O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.40
NPSR1 Q6W5P4 3/20 0.40
POLB P06746 3/20 0.40
HTT P42858 2/20 0.40
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
AKR1C1 Q04828 1/20 0.36
TSHR P16473 1/20 0.35
APEX1 P27695 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 2/20 0.34
HCAR3 P49019 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
OPRM1 P35372 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6553149 0.80 SLC6A4 (0.46) SLC6A4NPSR1POLBHTTMEN1
SCHEMBL29288548 0.76 SLC6A4 (0.43) SLC6A4NPSR1POLBHTTMEN1
SCHEMBL20242106 0.75 SLC6A4 (0.54) SLC6A4NPSR1POLBHTTMEN1
SCHEMBL7602755 0.72 AKR1C1 (0.50) SLC6A4NPSR1POLBHTTMEN1
SCHEMBL18441436 0.70 SLC22A1 (0.39) SLC6A4AKR1C1OPRM1
SCHEMBL5129613 0.69 AKR1C1 (0.47) SLC6A4NPSR1POLBHTTMEN1
SCHEMBL4639359 0.68 AKR1C1 (0.56) HTTMEN1KMT2ACYP2C9AKR1C1
SCHEMBL4814471 0.68 OPRM1 (0.34) SLC6A4POLBMEN1KMT2ACYP1A2
SCHEMBL19469690 0.67 ELOVL1 (0.47) SLC6A4NPSR1POLBHTTMEN1
SCHEMBL11444396 0.67 MEN1 (0.62) SLC6A4NPSR1POLBHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018107056-A1 1,3-SUBSTITUED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACIC LEVELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-06-14 WO disclosed